HSV, axonal transport and Alzheimer’s disease: in vitro and in vivo evidence for causal relationships

ISSN： 1746-0794

Source： Future Virology, Vol.7, Iss.9, 2012-09, pp. : 885-899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microtubule-stabilising drugs for therapy of Alzheimer’s disease and other neurodegenerative disorders with axonal transport impairments

By Trojanowski John Q Smith Amos B Huryn Donna Lee Virginia M-Y

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 683-686

Informa Healthcare

Access to resources Recommend Favorite

Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer’s Disease: in vitro and ex vivo Characterization

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 17, Iss. 1, 2018-04 ,pp. : 43-53

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding the relationship between ApoE and HSV-1 and its possible significance in Alzheimer’s disease

By Burgos Javier S Valdivieso Fernando

Future Virology, Vol. 2, Iss. 3, 2007-05 ,pp. : 239-242

Future Medicine

Access to resources Recommend Favorite

Commentary: Research Highlights ATF4: The Perpetrator in Axonal-Mediated Neurodegeneration in Alzheimer's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1483-1484

Bentham Science Publishers

Access to resources Recommend Favorite

Combination Therapy in Alzheimer’s Disease: A Review of Current Evidence

By Schmitt Beate

CNS Drugs, Vol. 18, Iss. 13, 2004-01 ,pp. : 827-844

Adis International

Access to resources Recommend Favorite